Can a plastic meniscus implant keep knees Pain-Free for years?
NCT ID NCT03953846
First seen Aug 27, 2026 · Last updated Sep 09, 2026 · Updated 2 times
Summary
This registry study follows people who receive the NUsurface meniscus implant, a device designed to replace a damaged meniscus in the knee. Researchers track pain and knee function over time using standard scores like KOOS and WOMET. The goal is to see how well the implant works and how safe it is in everyday use. Anyone who is new to the implant or already using it can join.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- NUsurface meniscus implant, a medical device placed in the knee to replace a damaged meniscus
- What this could lead to
- If the implant holds up over time, it could offer a lasting option for people with knee pain and early osteoarthritis who want to delay or avoid a knee replacement.
- What could go wrong
- This is an observational registry, not a controlled trial, so it cannot prove the implant works better than other treatments. Long-term safety and effectiveness are still being checked, and some people may not improve.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
36 people
The number who actually took part.
- Started
-
Jun 2019
- Finished
-
Nov 2023
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population eligible for this protocol includes any subject who received or is scheduled to receive the NUsurface® meniscus implant and meets the Registry inclusion criteria
- Ages
-
18 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * New or current treatment with the NUsurface® meniscus implant * Evidence of a personally signed and dated informed consent document indicating that the subject (or a legally acceptable representative) has been informed of all pertinent aspects of the Registry. Exclusion Criteria: * There are no protocol exclusion criteria; all subjects who meet the inclusion criteria are eligible for enrollment.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Knee osteoarthritis are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AZ Monica vzw
Deurne, BE-2100, Belgium
-
Klinikum der Universität München
München, 81377, Germany
-
Maastricht UMC
Maastricht, 6229HX, Netherlands
-
Shamir Medical Center
Ẕerifin, 70300, Israel
-
Sporthopaedicum
Berlin, 10627, Germany
-
University of Brandenburg
Brandenburg an der Havel, 14770, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- CBD oil may curb chronic pain after knee surgery
- Physical therapy may unlock lasting activity for older adults with joint pain
- Ear stimulation vs. steroid shots: a new test for knee pain relief
- Can a Screen-Based tai chi class soothe aching knees?
- Can a daily drink soothe aching knees?
- Can a smartphone replace a physio visit for older adults with knee arthritis?